ReveraGen BioPharma (United States)
Open Access statistics for ReveraGen BioPharma (United States), United States, covering academic research published from 2012 to 2024.
Open Access statistics for ReveraGen BioPharma (United States), United States, covering academic research published from 2012 to 2024. Read More.
Open Access Percentage
71%
Total
Publications
51
Total Open
Publications
36
Total
Citations
1.3K
Open Access
Percentage
71%
Total
Publications
51
Total Open
Publications
36
Total
Citations
1.3K
Breakdown
Publisher Open
10%
Both
46%
Other Platform Open
14%
Closed
30%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 43%
12
Hybrid 21%
6
No Guarantees 36%
10
Other Platform Open
Domain 84%
26
Institution 23%
7
Other Internet 16%
5
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 26 |
Europe PMC | Domain | 5 |
DOI | Other Internet | 5 |
University of Padua | Institution | 2 |
University of Melbourne | Institution | 2 |
universiteitleiden.nl OAI-PMH Repository | Institution | 1 |
Royal Netherlands Academy of Arts and Sciences | Institution | 1 |
Office of Scientific and Technical Information | Institution | 1 |
KU Leuven | Institution | 1 |
Australian National University | Institution | 1 |